Interaction between antiretroviral boosters and corticosteroids can lead to development of Cushing’s syndrome

An interaction between antiretroviral boosting agents and corticosteroids can lead to Cushing’s syndrome, according to French research published in the Journal of Antimicrobial Chemotherapy. Almost all the cases of Cushing’s syndrome identified among people with HIV were due to drug interactions between the boosting agents ritonavir or cobicistat and a corticosteroid. Moreover, the interaction was… Read More »